Skip to content
Fortis Malar Hospitals logo

Fortis Malar Hospitals

523696 BSE
₹40.32

Close ·

P/E
576.00
View as Markdown
MCP
Close 4 Nov 2026 ₹40.32 −25.24 −38.5% 1Y
Start ₹65.56

Key Fundamentals

MicrocapHealthcare ServicesHealthcare

Price-based figures at the close · EPS basis: Consolidated · TTM

ROCE
14.60%
Debt to Equity
0.00
EPS (TTM)
₹0.07
Book Value
₹18.32
Market Cap
—
P/E (TTM)
576.00
P/B
2.20
ROE
12.80%
Dividend Yield
107.32%
EBITDA
₹4.70 Cr
52W High
₹66.99
52W Low
₹39.00

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

50 Average

Data confidence 98/100

Category scores

Quality
53
Average
Returns, margins, earnings quality 22% weight
Valuation
33
Poor
Cheap vs sector & own history 24% weight
Growth
92
Strong
Sales & profit trajectory 9% weight
Financial Health
86
Strong
Solvency, leverage, coverage 9% weight
Momentum
17
Poor
Trend strength, vol-adjusted 12% weight
Ownership
50
Average
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

1
  • Company is almost debt free.

Weaknesses

2
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of -1.79% over last 3 years.

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bearish1054
OscillatorsNeutral252
Moving AveragesStrong Bearish802

Key readings

RSI (14)
45.17
Neutral
MACD (12,26,9)
−0.68
Bullish
SMA (50)
42.38
Bearish
SMA (200)
50.20
Bearish

As of

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
10Y−100.00%
5Y−100.00%
3Y−100.00%
1YZero base
TTM+50.00%

Net profit

Net profit growth by window
10Y−4.29%
5YTurned to profit
3YTurned to profit
1Y+961.54%
TTM−97.18%

Operating cash flow

Operating cash flow growth by window
10Y−24.62%
5YTurned positive
3Y−52.01%
1Y−59.74%
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
10YNo sales
5YNo sales
3YNo sales
1YNo sales
TTMTiny sales

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹141 Cr
Mar 2018₹149 Cr
Mar 2019₹145 Cr
Mar 2020₹112 Cr
Mar 2021₹69.24 Cr
Mar 2022₹86.18 Cr
Mar 2023₹85.95 Cr
Mar 2024₹59.01 Cr
Mar 2025₹0.00 Cr
Mar 2026₹0.00 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017₹3.11 Cr
Mar 2018₹3.32 Cr
Mar 2019₹2.06 Cr
Mar 2020−₹8.89 Cr
Mar 2021−₹7.87 Cr
Mar 2022−₹8.27 Cr
Mar 2023−₹15.48 Cr
Mar 2024₹45.32 Cr
Mar 2025₹0.39 Cr
Mar 2026₹4.14 Cr

Quarterly Results

₹ Cr
523696 quarterly results, ₹ crore
Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
17.76
18.15
17.58
5.52
0
0
0
0
0.02
0.03
0
0
0
Expenses
18.27
18.23
18.67
5.04
0.88
0.47
0.41
0.37
0.35
0.41
0.33
0.55
0.33
Operating Profit
−0.51
−0.08
−1.09
0.48
−0.88
−0.47
−0.41
−0.37
−0.33
−0.38
−0.33
−0.55
−0.33
OPM %
−2.87%
−0.44%
−6.2%
8.7%
—
—
—
—
Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number.
Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number.
—
—
—
Other Income
1.61
2.31
1.26
59.69
0.83
0.56
0.56
0.77
4.61
0.52
0.52
0.66
0.53
Interest
1.35
1.3
1.26
0.39
0.01
0
0
0
0
0
0
0
0
Depreciation
2.67
2.72
2.91
1.06
0
0
0
0
0
0
0
0
0
PBT
−2.92
−1.79
−4
58.72
−0.06
0.09
0.15
0.4
4.28
0.14
0.19
0.11
0.2
Tax %
0%
0%
0.25%
7.95%
0%
0%
93.33%
10%
3.04%
92.86%
89.47%
136.36%
25%
Net Profit
−2.93
−1.79
−4
54.05
−0.06
0.09
0.01
0.36
4.15
0.01
0.02
−0.05
0.15
EPS (₹)
−1.56
−0.96
−2.13
28.84
−0.03
0.05
0.01
0.19
2.21
0.01
0.01
−0.03
0.08

Profit & Loss

₹ Cr
523696 profit and loss, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
118
130
141
149
145
112
69.24
86.18
85.95
59.01
0
0
0.03
Expenses
110
123
140
147
147
115
75.58
82.74
81.38
60.22
2.14
1.62
1.62
Operating Profit
7.56
6.3
0.92
1.75
−2.35
−2.7
−6.34
3.44
4.57
−1.21
−2.14
−1.62
−1.59
OPM %
6.41%
4.86%
0.65%
1.17%
−1.63%
−2.41%
−9.16%
3.99%
5.32%
−2.05%
—
Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number.
Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number.
Other Income
7.63
7.21
7.95
8.44
10.03
11.11
15.1
7.39
6.64
64.88
2.72
6.35
2.23
Interest
0.51
0.4
0.46
0.38
0.51
7.81
7.2
6.56
6.07
4.3
0.01
0
0
Depreciation
2.71
3.16
3.94
4.21
4.38
12.53
12.88
12.53
12.15
9.36
0
0
0
PBT
11.97
9.95
4.47
5.6
2.79
−11.93
−11.32
−8.26
−7.01
50.01
0.57
4.73
0.64
Tax %
34.25%
35.58%
30.2%
40.54%
26.16%
−25.48%
−30.48%
0.12%
120.97%
9.36%
31.58%
12.47%
—
Net Profit
7.86
6.42
3.11
3.32
2.06
−8.89
−7.87
−8.27
−15.48
45.32
0.39
4.14
0.13
EPS (₹)
4.23
3.45
1.67
1.78
1.1
−4.74
−4.2
−4.41
−8.26
24.18
0.21
2.21
0.07
Div. Payout %
11.84%
14.5%
0%
0%
0%
0%
0%
0%
0%
175.93%
0%
0%
—

Balance Sheet

₹ Cr
523696 balance sheet, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
18.61
18.62
18.68
18.7
18.76
18.76
18.76
18.76
18.76
18.76
18.76
18.76
Reserves
72.63
79.02
80.87
84.35
86.62
77.65
69.99
61.37
45.42
90.71
11.45
15.59
Borrowings
0
0
0
0
0
64.34
57.17
53.41
46.4
0
0
0
Other Liabilities
19.68
32.55
31.14
46.03
45.46
32.8
23.18
27.37
27.42
6.41
6.62
3.26
Total Liabilities
111
130
131
149
151
194
169
161
138
116
36.83
37.61
Fixed Assets
17.71
24.5
24.59
23.79
21.85
81.08
68.52
57.62
47.41
0
0
0
CWIP
0.64
0.36
0.61
0.72
0.73
0.09
0.36
0.06
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
92.57
105
105
125
128
112
100
103
90.59
116
36.83
37.61
Total Assets
111
130
131
149
151
194
169
161
138
116
36.83
37.61

Cash Flow

₹ Cr
523696 cash flow, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
4.39
10.47
−8.58
8.79
−15.97
−0.3
−0.86
6.84
5.61
−7.3
1.54
0.62
Investing
5.34
−21.88
13.47
−1.56
6.34
49.88
−27.51
8.23
0.5
120
−29.1
0.46
Financing
0
−1.09
−0.97
0.05
0.15
−11.57
−7.25
−10.1
−12.65
−10.85
−79.65
0
Net Cash Flow
9.73
−12.51
3.92
7.28
−9.48
38.01
−35.62
4.98
−6.54
102
−107
1.08
Free Cash Flow
1.11
−0.1
−12.14
5.11
−18.68
−3.2
−1.39
5.56
3.73
−9.6
1.54
0.62
CFO/OP
133
235
−175
801
458
−143
204
220
121
188
81
51

Ratios

523696 financial ratios, annual
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
13.03
16.93
14.49
14.68
24.39
12.17
11.02
9.32
13.5
0
—
—
Inventory Days
13.24
35.39
28.37
22.3
18.04
22.44
42.32
39.89
31.71
0
—
—
Days Payable
169
286
174
277
257
324
373
429
585
—
—
—
Cash Conversion Cycle
−143
−234
−131
−240
−215
−289
−320
−380
−539
0
—
—
Working Capital Days
164
126
153
132
156
−55.01
115
21.6
184
−8.35
—
—
ROCE %
14.19%
11.83%
5.02%
5.9%
3.24%
−3.04%
−7.15%
−1.25%
−0.77%
−3.29%
0.83%
14.65%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Fortis Malar Hospitals insights

54 extracted metrics across FY11–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 62.71%
  • Public 29.48%
  • Others 7.74%
  • DIIs 0.07%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Not shown for some quarters: Others. Not available separately for this quarter: the shareholding filing gives Public and Others as one figure, shown under Public, so Others is left blank rather than estimated.

Documents

Frequently Asked Questions about Fortis Malar Hospitals

What does Fortis Malar Hospitals Ltd do?
Incorporated in 1992, Fortis Malar Hospital Ltd is in the business of setting up, managing, and operating a multi-speciality hospital.
Where is Fortis Malar Hospitals Ltd (FORTISMLR) listed?
Fortis Malar Hospitals Ltd trades under code 523696 on the BSE.
Which sector does Fortis Malar Hospitals Ltd belong to?
Fortis Malar Hospitals Ltd is classified under the Healthcare Services sector, in the Hospitals industry.
What is the PE ratio of Fortis Malar Hospitals Ltd?
Fortis Malar Hospitals Ltd trades at a PE ratio of 576.00 as of 4 Nov 2026, on earnings per share of ₹0.07, against a book value of ₹18.32 per share.
What is the 52-week high and low of Fortis Malar Hospitals Ltd?
Over the last 52 weeks Fortis Malar Hospitals Ltd has traded between ₹39 and ₹66.99 as of 4 Nov 2026.
Does Fortis Malar Hospitals Ltd pay dividends?
Fortis Malar Hospitals Ltd has a dividend yield of 107.32%.
What is the Return on Equity (ROE) of Fortis Malar Hospitals Ltd?
Fortis Malar Hospitals Ltd reported a return on equity of 12.80%. Its debt-to-equity ratio is 0.00.

Company Information

Incorporated in 1992, Fortis Malar Hospital Ltd is in the business of setting up, managing, and operating a multi-speciality hospital.

Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/523696.md for Fortis Malar Hospitals Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More